Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folate Levels with Oral Contraceptives + Folic Acid
NCT00301587Phase 3Withdrawn
- Sponsor
- Johnson & Johnson
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of norgestimate + ethinyl estradiol + folic acid in neural tube defects (NTDs), sponsored by Johnson & Johnson. Status: withdrawn.
02
Drugs
norgestimate + ethinyl estradiol + folic acid
03
Conditions
neural tube defects (NTDs)
Beyond the preview
Go deeper on NCT00301587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301587.